Amherst, N.Y. -  

Dent Neurologic Institute in Amherst is partnering with a Lewiston business to become a clinical research center for the use of medical marijuana.

Dent and Herbal Agriculture will be working together to develop treatment and protocol for treating neurological disorders with marijuana.

DNI’s Chief Medical Officer, Laszlo Mechtler states “We are pleased to have partnered with HA to develop protocols for the treatment of NYS approved neurological disorders, which includes, ALS (Lou Gehrig’s disease), Parkinson’s disease, Multiple Sclerosis (MS), spinal cord injury, epilepsy, neuropathies and Huntington’s disease. Additionally, the DNI will focus on clinical protocols involving patients with chronic migraine and Post Traumatic Stress Disorder. We fully anticipate advancing the science, treatment and research on behalf the individual patients and their families whom could benefit greatly from medical marijuana’s therapeutic benefits.

Gary Smith, Chief Operating Officer of Herbal Agriculture comments “We are extremely excited about our...